FDA Inspection 1204144 — Similasan AG
The FDA completed an inspection of Similasan AG on Apr 4, 2023 in Jonen. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 4, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jonen (Switzerland)